Exchange: NASDAQ·Updated 07:42 PM EDT

PODD News

News
all
press releases
Insulet Announces Omnipod Discover Now Available in U.S.
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced the U.S. full market release of Omnipod Discover, a web-based data platform designed for Omnipod 5 users, their caregivers, and healthcare providers (HCPs...
Business Wire
Insulet Announces Omnipod Discover Now Available in U.S.
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced the U.S. full market release of Omnipod Discover, a web-based data platform designed for Omnipod 5 users, their caregivers, and healthcare providers (HCPs...
Business Wire
More News
Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced it will report financial results for the third quarter of 2026 on Wednesday, November 4, 2026, before the opening of the financial...
Business Wire
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors 3rd Annual Healthcare Forum
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced that management will present at Bernstein Insights: Healthcare Leaders and Disruptors 3rd Annual Healthcare Forum on Thursday, September 24, 2026, at 12:30...
Business Wire
Here's Why Insulet (PODD) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?
PODD's Omnipod 5 adoption, product expansion and raised international growth outlook support its growth prospects despite competitive and cost pressures.
Zacks
Insulet (PODD) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?
Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
PODD DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Insulet Corporation (Insulet or the Company) (NASDAQ: PODD) and reminds investors of the August 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has...
Business Wire
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation (Insulet or the Company) (NASDAQ: PODD) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated...
Business Wire

Advertisement|Remove ads.